Cargando…

Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden

BACKGROUND: Rheumatoid factors (RFs) and antibodies against cyclic citrullinated peptides (CCPs) of IgG, IgA and IgM isotype have been shown to precede disease onset by years. OBJECTIVE: To evaluate serological risk markers in first-degree relatives from multicase families in relation to genetic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ärlestig, Lisbeth, Mullazehi, Mohammed, Kokkonen, Heidi, Rocklöv, Joacim, Rönnelid, Johan, Dahlqvist, Solbritt Rantapää
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371219/
https://www.ncbi.nlm.nih.gov/pubmed/22128080
http://dx.doi.org/10.1136/annrheumdis-2011-200668
_version_ 1782235180047532032
author Ärlestig, Lisbeth
Mullazehi, Mohammed
Kokkonen, Heidi
Rocklöv, Joacim
Rönnelid, Johan
Dahlqvist, Solbritt Rantapää
author_facet Ärlestig, Lisbeth
Mullazehi, Mohammed
Kokkonen, Heidi
Rocklöv, Joacim
Rönnelid, Johan
Dahlqvist, Solbritt Rantapää
author_sort Ärlestig, Lisbeth
collection PubMed
description BACKGROUND: Rheumatoid factors (RFs) and antibodies against cyclic citrullinated peptides (CCPs) of IgG, IgA and IgM isotype have been shown to precede disease onset by years. OBJECTIVE: To evaluate serological risk markers in first-degree relatives from multicase families in relation to genetic and environmental risk factors. METHODS: 51 multicase families consisting of 163 individuals with rheumatoid arthritis (RA) (mean±SD age, 60±14 years; disease duration 21 years; 71.8% female) and with 157 first-degree relatives unaffected by RA (54±17 years; 59.9% female) were recruited. Isotypes of antibodies against CCPs (IgG, IgA and IgM) and RFs (IgM and IgA) were determined using automated enzyme immunoassays. Cut-off levels were established using receiver operating characteristic curves based on values for 100 unrelated healthy controls. RESULTS: The concentrations and frequencies of all anti-CCP and RF isotypes were significantly increased in first-degree relatives and patients with RA compared with unrelated healthy controls. The relative distribution of IgA and IgM isotypes was higher than IgG in the relatives, whereas the IgG isotype dominated in patients with RA. The patients carried human leucocyte antigen-shared epitope (HLA-SE) significantly more often than the relatives (71.4% vs 53.9%, p=0.01), while the frequency of the PTPN22 T variant was similar. HLA-SE, combined with smoking, was significantly related to all combinations of anti-CCP and RF isotypes in patients with RA. No such relationships were found for the first-degree relatives. CONCLUSIONS: All anti-CCP and RF isotypes analysed occurred more commonly in unaffected first-degree relatives from multicase families than in controls, but with different isotype distribution from patients with RA.
format Online
Article
Text
id pubmed-3371219
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-33712192012-06-11 Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden Ärlestig, Lisbeth Mullazehi, Mohammed Kokkonen, Heidi Rocklöv, Joacim Rönnelid, Johan Dahlqvist, Solbritt Rantapää Ann Rheum Dis Clinical and Epidemiological Research BACKGROUND: Rheumatoid factors (RFs) and antibodies against cyclic citrullinated peptides (CCPs) of IgG, IgA and IgM isotype have been shown to precede disease onset by years. OBJECTIVE: To evaluate serological risk markers in first-degree relatives from multicase families in relation to genetic and environmental risk factors. METHODS: 51 multicase families consisting of 163 individuals with rheumatoid arthritis (RA) (mean±SD age, 60±14 years; disease duration 21 years; 71.8% female) and with 157 first-degree relatives unaffected by RA (54±17 years; 59.9% female) were recruited. Isotypes of antibodies against CCPs (IgG, IgA and IgM) and RFs (IgM and IgA) were determined using automated enzyme immunoassays. Cut-off levels were established using receiver operating characteristic curves based on values for 100 unrelated healthy controls. RESULTS: The concentrations and frequencies of all anti-CCP and RF isotypes were significantly increased in first-degree relatives and patients with RA compared with unrelated healthy controls. The relative distribution of IgA and IgM isotypes was higher than IgG in the relatives, whereas the IgG isotype dominated in patients with RA. The patients carried human leucocyte antigen-shared epitope (HLA-SE) significantly more often than the relatives (71.4% vs 53.9%, p=0.01), while the frequency of the PTPN22 T variant was similar. HLA-SE, combined with smoking, was significantly related to all combinations of anti-CCP and RF isotypes in patients with RA. No such relationships were found for the first-degree relatives. CONCLUSIONS: All anti-CCP and RF isotypes analysed occurred more commonly in unaffected first-degree relatives from multicase families than in controls, but with different isotype distribution from patients with RA. BMJ Group 2011-11-29 /pmc/articles/PMC3371219/ /pubmed/22128080 http://dx.doi.org/10.1136/annrheumdis-2011-200668 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Clinical and Epidemiological Research
Ärlestig, Lisbeth
Mullazehi, Mohammed
Kokkonen, Heidi
Rocklöv, Joacim
Rönnelid, Johan
Dahlqvist, Solbritt Rantapää
Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
title Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
title_full Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
title_fullStr Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
title_full_unstemmed Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
title_short Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
title_sort antibodies against cyclic citrullinated peptides of igg, iga and igm isotype and rheumatoid factor of igm and iga isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern sweden
topic Clinical and Epidemiological Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371219/
https://www.ncbi.nlm.nih.gov/pubmed/22128080
http://dx.doi.org/10.1136/annrheumdis-2011-200668
work_keys_str_mv AT arlestiglisbeth antibodiesagainstcycliccitrullinatedpeptidesofiggigaandigmisotypeandrheumatoidfactorofigmandigaisotypeareincreasedinunaffectedmembersofmulticaserheumatoidarthritisfamiliesfromnorthernsweden
AT mullazehimohammed antibodiesagainstcycliccitrullinatedpeptidesofiggigaandigmisotypeandrheumatoidfactorofigmandigaisotypeareincreasedinunaffectedmembersofmulticaserheumatoidarthritisfamiliesfromnorthernsweden
AT kokkonenheidi antibodiesagainstcycliccitrullinatedpeptidesofiggigaandigmisotypeandrheumatoidfactorofigmandigaisotypeareincreasedinunaffectedmembersofmulticaserheumatoidarthritisfamiliesfromnorthernsweden
AT rocklovjoacim antibodiesagainstcycliccitrullinatedpeptidesofiggigaandigmisotypeandrheumatoidfactorofigmandigaisotypeareincreasedinunaffectedmembersofmulticaserheumatoidarthritisfamiliesfromnorthernsweden
AT ronnelidjohan antibodiesagainstcycliccitrullinatedpeptidesofiggigaandigmisotypeandrheumatoidfactorofigmandigaisotypeareincreasedinunaffectedmembersofmulticaserheumatoidarthritisfamiliesfromnorthernsweden
AT dahlqvistsolbrittrantapaa antibodiesagainstcycliccitrullinatedpeptidesofiggigaandigmisotypeandrheumatoidfactorofigmandigaisotypeareincreasedinunaffectedmembersofmulticaserheumatoidarthritisfamiliesfromnorthernsweden